TECH - CIK 0000842023
The table below shows BIO-TECHNE Corp's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $209.82M | $172.88M | $144.96M | $140.67M | $177.55M | $187.54M |
| Short-term investments | - | - | - | $0.00 | $0.00 | $1.07M |
| Receivables | $214.56M | $184.61M | $183.90M | $237.14M | $217.94M | $223.69M |
| Inventory | $201.18M | $205.45M | $203.19M | $191.08M | $188.37M | $185.04M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $688.05M |
| $637.43M |
| $609.51M |
| $627.24M |
| $634.64M |
| $648.57M |
| Property, plant & equipment | $232.99M | $234.38M | $240.33M | $251.98M | $249.75M | $253.94M |
| Goodwill | $977.80M | $980.56M | $978.91M | $968.61M | $964.61M | $982.59M |
| Total assets | $2.55B | $2.52B | $2.53B | $2.64B | $2.67B | $2.74B |
| Accounts payable | $23.49M | $26.27M | $30.16M | $31.64M | $33.12M | $31.56M |
| Total current liabilities | $153.28M | $140.43M | $144.54M | $169.20M | $161.26M | $142.13M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | $1.15B | $1.11B | $1.08B | $1.20B | $1.29B | $1.34B |
| Total equity | $2.09B | $2.01B | - | $2.02B | $2.08B | $2.14B |